RenovoRx Changes Auditors

Ticker: RNXT · Form: 8-K · Filed: May 3, 2024 · CIK: 1574094

Renovorx, INC. 8-K Filing Summary
FieldDetail
CompanyRenovorx, INC. (RNXT)
Form Type8-K
Filed DateMay 3, 2024
Risk Levelmedium
Pages3
Reading Time4 min
Key Dollar Amounts$17.2 million, $390,000, $235,000, $227,587, $325,000
Sentimentneutral

Sentiment: neutral

Topics: auditor-change, accounting

TL;DR

RenovoRx just lost its auditor, WithumSmith+Brown, PC, and is looking for a new one.

AI Summary

RenovoRx, Inc. announced on May 3, 2024, that their independent registered public accounting firm, WithumSmith+Brown, PC, has resigned. The company is in the process of selecting a new accounting firm and expects to complete this process within the next few weeks. This change follows the resignation of WithumSmith+Brown, PC, effective April 29, 2024.

Why It Matters

A change in auditors can sometimes signal underlying issues with financial reporting or internal controls, potentially impacting investor confidence.

Risk Assessment

Risk Level: medium — A change in auditors, especially if not due to a planned transition, can raise questions about financial reporting and internal controls.

Key Players & Entities

FAQ

Who is RenovoRx, Inc.'s former independent registered public accounting firm?

RenovoRx, Inc.'s former independent registered public accounting firm was WithumSmith+Brown, PC.

When did WithumSmith+Brown, PC's resignation become effective?

The resignation of WithumSmith+Brown, PC became effective on April 29, 2024.

What is the reason provided for the auditor's resignation?

The filing does not explicitly state a reason for the auditor's resignation, only that they have resigned.

When does RenovoRx, Inc. expect to appoint a new accounting firm?

RenovoRx, Inc. expects to complete the selection of a new independent registered public accounting firm within the next few weeks.

What is the filing date of this 8-K report?

This 8-K report was filed on May 3, 2024.

Filing Stats: 948 words · 4 min read · ~3 pages · Grade level 12.6 · Accepted 2024-05-03 17:00:17

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RenovoRx, Inc. Date: May 3, 2024 By: /s/ Shaun Bagai Name: Shaun R. Bagai Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing